Rheumazentrum Ruhrgebiet

Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany () Friedrich R, Kernder A, Blank N, Ernst D, Henes J, Keyßer G, Klemm P, et al. Journal article First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study (2025) Kernder A, Filla T, Friedrich R, Blank N, Ernst D, Henes J, Keyßer G, et al. Journal article No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry (2024) Regierer AC, Kiefer D, Schett G, Krause A, Weiß A, Sewerin P, Strangfeld A Journal article Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage (2024) Zabotti A, Fagni F, Gossec L, Giovannini I, Sticherling M, Tullio A, Baraliakos X, et al. Journal article Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry (2024) Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, Krickau T, et al. Journal article, Original article DNVF Memorandum - Ziele und Methoden bewegungsbezogener Versorgungsforschung (2024) Gabrys L, Schaller A, Peters S, Barzel A, Berrisch-Rahmel S, Dreinhöfer KE, Eckert K, et al. Journal article EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update (2024) Gossec L, Kerschbaumer A, Ferreira RJ, Aletaha D, Baraliakos X, Bertheussen H, Boehncke WH, et al. Journal article Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST. (2024) Proft F, Vossen D, Baraliakos X, Berliner MN, Fleck M, Keyßer G, Krause A, et al. Journal article Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial (2023) Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, et al. Journal article Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice (2023) Werner SG, Baraliakos X, Reckert S, Bohl-Bühler M, Laliberté MC, Girard T, Jeromin K, et al. Journal article